Zurueck zur Suche

Reporte zur Charge UJ723AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

36Reporte angezeigt
1Todesfaelle
2Hospitalisiert
1Lebensbedrohlich
2Bleibende Schaeden
OH 8 TX 3 MI 3 IL 2 MA 2 TN 2 FL 2 MN 1 ID 1 AR 1 NY 1 WA 1

VAERS 2101786

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge UJ723AA

kritisch
Staat
MN
Alter
61,0
Geschlecht
F
Eingang
10.02.2022
Impfdatum
14.10.2021
Beginn
01.11.2021
Tage bis Beginn
18,0
Dosis
3
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Blood test Computerised tomogram Death Endoscopy Feeding disorder Nausea Pancreatic cyst

Symptomtext

Patient was unable to eat within 2 weeks of the second Covid-19 shot. Her nausea got worse and worse until she went back into the doctor on 12/1 and it was found that she has many large cysts surrounding her pancreas. Patient made several appointments with some having to schedule months out due to availability. Died 1/13/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
13,0
Labordaten
Blood work 9/23/21, 12/1/2021, 1/1/2022 CT scan 12/1/2021, 1/2/2022 Endoscopy 1/2/2022
Aktuelle Erkrankungen
Gout Fatty Liver Acid Reflux High Blood Pressure Cronic Kidney Disease Stage IV Vitamin D Deficiency Parathyroid Disorders Pancreatitis
Vorgeschichte
High Blood Pressure Cronic Kidney Disease Stage IV Pancreatitis
Andere Medikamente
allopurinol 100 mg tablet carvedilol 25 mg tablet furosemide 20 mg tablet omeprazole 20 mg delayed release capsule hydrALAZINE 100 mg tablet
Allergien
Isosorbide Atorvastatin Simvastatin
Vorherige Impfungen
-

VAERS 1704621

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

kritisch
Staat
MI
Alter
72,0
Geschlecht
F
Eingang
16.09.2021
Impfdatum
14.09.2021
Beginn
14.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Blindness unilateral Cerebrovascular accident Computerised tomogram head abnormal Hemianopia

Symptomtext

Within minutes of receiving the vaccine the patient suffered a right-sided visual loss consistent with a hemi-anopsia. She saw an eye specialist the following day and was sent emergently to the hospital where a CT showed a new left occipital lobe CVA

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
4,0
Labordaten
CAT scan
Aktuelle Erkrankungen
-
Vorgeschichte
diabetes,depression
Andere Medikamente
lipitor,toprol,norvasc, ASA, wellbutrin,premerin,glucotrol,levemir,aldactone
Allergien
sulfa iodine
Vorherige Impfungen
-

VAERS 2010408

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

schwer
Staat
SD
Alter
-
Geschlecht
F
Eingang
06.01.2022
Impfdatum
28.10.2021
Beginn
15.11.2021
Tage bis Beginn
18,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Electromyogram abnormal Guillain-Barre syndrome Neuralgia SARS-CoV-2 test negative Streptococcus test positive

Symptomtext

11/15/21 neuropathic pain noted to feet 11/19/21 neuropathic pain has spread to both upper and lower extremities. 11/22/21 provider appt - EMG ordered gabapentin initiated 11/26/21 neuropatic pain increased severly and an ER visit indicated negative COVID test, positive Strep test. neurology consulted and 1gm Rocpehon Iv x 4 days initiated 11/30/21 neurology evalution with EMG & nerve conduction study revealed Acute Demylinating Polyradiculoneuropathy 12/1/21 Gammaguard infusions initiated X 5 doses.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Guillain-Barre syndrome
Hospital-Tage
-
Labordaten
11/30/21 EMG / muscle conduction study - acute demylinating polyradiculoneuropathy
Aktuelle Erkrankungen
tested positive for strep after symptoms started
Vorgeschichte
hyperlipidemia, chronic pain
Andere Medikamente
Lipitor, Estrodial, Imiprimine, Hydrocodone, Bacolfen, Oxybutnin, Vitamin B12, Vitamn D3, Magnesium, Potassium, Biotin
Allergien
no known allergies
Vorherige Impfungen
02/28/21 COVID 19 vaccination - 2nd dose of Moderna caused elevated temperature, headache ache, severe body aches and lethar

VAERS 1942038

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

schwer
Staat
OH
Alter
40,0
Geschlecht
M
Eingang
11.12.2021
Impfdatum
10.12.2021
Beginn
10.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Loss of consciousness Presyncope

Symptomtext

PT received the Pfizer booster vaccine and flu vaccine , PT described feeling light headed and dizzy about 4 minutes after the vaccine administration, Pt crossed his legs to help ease his symptoms as this has worked in the past. PT vasovagal and regained consciousness about 5 seconds later. Pt states that he felt like he just went to sleep. Pt was provided water at his request. Pt admitted to not eating before receiving the vaccination. Pt stated that he felt fine about 2 minutes after regaining consciousness and waited 30 minutes before leaving the clinic.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
No recent or current illnesses
Vorgeschichte
none
Andere Medikamente
No medications, supplements, or herbal remedies being taken.
Allergien
No allergies
Vorherige Impfungen
1 st dose of pfizer vaccine, in May (no date provided)

VAERS 1904116

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

schwer
Staat
OH
Alter
30,0
Geschlecht
M
Eingang
27.11.2021
Impfdatum
27.11.2021
Beginn
27.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cold sweat Dizziness Interchange of vaccine products Pallor Paraesthesia Presyncope

Symptomtext

On 11/27/21, Patient presented to clinic to receive both Pfizer COVID booster vaccine (after receiving J&J COVID vaccine 06/05/2021) as well as flu vaccine. Pt was sitting in chair and became nervous before vaccine administered. Denied any issues with prior vaccines. After Flublok vaccine was administered in left deltoid at 4:11pm, pt quickly became pale and clammy. Pt continue to have vasovagal response, but provider able to hold patient up in chair. After only a minute, patient able to speak but still felt clammy with tingling in hands and light-headed. Pt was told to lie down on exam table with feet up and cold towel placed on forehead. Pt was able to speak but was told to rest for a bit. Door left open so staff could assist as needed. After 10 minutes or so, patient stated he still wanted to receive COVID vaccine booster. While pt was lying down, Pfizer booster administered in right deltoid. Pt did not have vasovagal response and radial pulse remained strong and regular. Pt was told to remain reclined for a few more minutes. After an additional 10 minutes or so, pt able to leave clinic with steady gait.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1822591

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

moderat
Staat
OR
Alter
56,0
Geschlecht
F
Eingang
27.10.2021
Impfdatum
12.10.2021
Beginn
12.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dyspnoea Nausea Oropharyngeal pain Pyrexia Vaccine positive rechallenge

Symptomtext

Nausea, Shortness of breath, low grade fever 99-100, sore throat

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Methocarbamol, Vyvanse, estradiol, Ventolin, valacyclovir
Allergien
tylenol, amoxicillin, belladona alkaloids, morphine, macrolides, nsaids, nystatin, sulfa
Vorherige Impfungen
she received the Pfizer doses 1 and 2 in Feb 2021 and she got same side effects but each time was progresively worse

VAERS 2206539

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

mild
Staat
MD
Alter
51,0
Geschlecht
F
Eingang
30.03.2022
Impfdatum
22.12.2021
Beginn
22.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Pain Pain in extremity

Symptomtext

Received the annual flu vaccination on 12/22/21 in my left arm. My arm/shoulder were sore. I took tylenol and ibuprofen for the soreness/pain for the next few days. It never got better and my arm hurts all of the time. I still have movement in it, but it hurts to lift over my head or in certain directions. It is constantly sore/pain. I have tried my own physical therapy on it and it does not help. I just keep hoping that it will get better and go away.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
going to seek medical attention through my primary physician in one week.
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Multi vit. Vit D Zinc
Allergien
None known
Vorherige Impfungen
-

VAERS 1967519

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge uj723aa

mild
Staat
OH
Alter
53,0
Geschlecht
F
Eingang
21.12.2021
Impfdatum
20.12.2021
Beginn
20.12.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site induration Injection site pain Injection site pruritus Injection site swelling Injection site warmth

Symptomtext

Almost immediatley after receiving vaccine patient experienced intense itching and burning at injection site and within 30 minutes swelling started as well. Reports soreness, and hardness, and swelling. Patient examined it visually at home and circled reaction with a pen at 1:39 pm and site was around 2 inches by 3 inches large. By 11am 12/21/21 patient came back to pharmacy to report reaction and area of reaction was around the same size but had shifted down about one inch on arm. Patient still reports heat, swelling and itching from reaction site but that it is slightly more mild than yesterday. She hasn't taken any medications for symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site induration
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
High blood pressure
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1897146

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge uj723aa

mild
Staat
MI
Alter
49,0
Geschlecht
F
Eingang
24.11.2021
Impfdatum
19.11.2021
Beginn
19.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pruritus Urticaria Wheezing

Symptomtext

wheezing, itchy, chest hives

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
asthma, fibromyalgia ,rheumatoid arthritis
Andere Medikamente
albuterol, symbicory, ativan ,prilosec
Allergien
amox, cepholexin, latex, ms peanuts erythromycin tetanous vaccine
Vorherige Impfungen
-

VAERS 1832372

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

mild
Staat
AZ
Alter
67,0
Geschlecht
F
Eingang
31.10.2021
Impfdatum
29.10.2021
Beginn
30.10.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Induration Injection site induration Pruritus Skin warm

Symptomtext

Pt called and spoke to me and explained that her arm had turned red and hard from the injection site down towards the elbow and was about 4 inches tall, She too said that it then wrapped around to the back side of her arm in that 4 inch strip to where it stopped about midarm. She said it was warm to hot to the touch, somewhat itchy as well. Pt said that she was taking Benedryl to try and counter the reaction. She came in and saw me today and showed her arm to me. She said it was looking somewhat better than it did yesterday. She said it was still warm to the touch but not as red today.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site induration
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None known
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
NO Know allergies
Vorherige Impfungen
She only stated that a previous shot caused the same kind of a reaction

VAERS 1818571

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

mild
Staat
VA
Alter
56,0
Geschlecht
F
Eingang
26.10.2021
Impfdatum
14.10.2021
Beginn
15.10.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site pain Injection site swelling Injection site warmth

Symptomtext

From injection site to right elbow, from anterior to posterior arm was red, hot swollen, painful, burning for two days on day three it started to resolve with the application of warm soaks. Saw the Workers Comp doctor and my PCP.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
arthritis in R knee
Andere Medikamente
wellbutrin, etodelac, buspar, detrol, xanax
Allergien
libruim
Vorherige Impfungen
-

VAERS 1762860

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

mild
Staat
TX
Alter
39,0
Geschlecht
M
Eingang
05.10.2021
Impfdatum
01.10.2021
Beginn
03.10.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Pain in extremity

Symptomtext

Patient had a sore arm and redness.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
methylphenidate 36er
Allergien
none
Vorherige Impfungen
-

VAERS 1754732

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

mild
Staat
OH
Alter
39,0
Geschlecht
F
Eingang
01.10.2021
Impfdatum
01.10.2021
Beginn
01.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Abdominal discomfort Dizziness

Symptomtext

Patient felt as if she would pass out and as if she needed to have diarrhea; resolved with positioning, time and application of cool rag over 10 minutes without LOC.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1750494

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

mild
Staat
TX
Alter
94,0
Geschlecht
M
Eingang
30.09.2021
Impfdatum
23.09.2021
Beginn
24.09.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Injection site reaction Skin infection

Symptomtext

patient reported a skin infection on the injection site after getting the vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site reaction
Hospital-Tage
-
Labordaten
unknown.
Aktuelle Erkrankungen
unknown
Vorgeschichte
-
Andere Medikamente
unknown
Allergien
nkda
Vorherige Impfungen
-

VAERS 1749518

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

mild
Staat
TX
Alter
41,0
Geschlecht
F
Eingang
30.09.2021
Impfdatum
25.09.2021
Beginn
26.09.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hypersensitivity Rash Urticaria

Symptomtext

I asked if there was any swelling or redness at the injection site and she said no. Patient states that she had an overall body rash 24 hours after the vaccine that looked more live hives. She said she took benadryl and that helped significantly. Patient states hives have diminished with the passing of each day. I suggested she take a second antihistamine such as Zyrtec or Claritin during the day and she said she would. Will follow up with patient to see how she is doing in 24 hours. She was not sure if it was the vaccine or if it was something she came across that caused her to have an allergic reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
None reported
Aktuelle Erkrankungen
None reported
Vorgeschichte
None reported
Andere Medikamente
None reported
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1735800

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723aa

mild
Staat
FL
Alter
62,0
Geschlecht
F
Eingang
26.09.2021
Impfdatum
22.09.2021
Beginn
26.09.2021
Tage bis Beginn
4,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Headache Rhinorrhoea

Symptomtext

Patient called stating that she received her flu vaccine and today experiencing chills, headache and runny nose. Advised patient to follow up with doctor. Per patient she is seeing her doctor tomorrow.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1735770

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

mild
Staat
FL
Alter
46,0
Geschlecht
F
Eingang
26.09.2021
Impfdatum
14.09.2021
Beginn
15.09.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site bruising Injection site haematoma Injection site pain

Symptomtext

Pain in injection site, bruising (hematoma like) for about 2 weeks

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Levothyroxine
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1726764

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge uj723aa

mild
Staat
-
Alter
53,0
Geschlecht
F
Eingang
23.09.2021
Impfdatum
22.09.2021
Beginn
22.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Peripheral swelling Skin warm Urticaria

Symptomtext

swelling spread 7 inches wide and long below injection site/hives , warm to touch

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
allegra
Allergien
-
Vorherige Impfungen
-

VAERS 1724091

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

mild
Staat
CA
Alter
54,0
Geschlecht
F
Eingang
22.09.2021
Impfdatum
18.09.2021
Beginn
18.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Feeling hot Injection site pruritus

Symptomtext

AROUND 1 PM PATIENT START ITCHING AT THE POINT OF INJECTION AND THEN IT SWALLOW AND FELT WARM PATIENT TOOK IBUPROFEN 200 MG ONCE A DAY FOR 3 DAY AND ALL SYMPTOMS DISAPEARED ON TUESDAY 09/21/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NO
Vorgeschichte
NO
Andere Medikamente
NO
Allergien
NO
Vorherige Impfungen
SHINGRIX FLU LIKE SYMPTOMS

VAERS 1701318

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

mild
Staat
SC
Alter
29,0
Geschlecht
F
Eingang
15.09.2021
Impfdatum
15.09.2021
Beginn
15.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Blood pressure increased Dizziness Feeling hot Heart rate increased

Symptomtext

Pt was okay immediately following the shots. She became hot, lightheaded and weak about 15 minutes later. BP and HR were very slightly elevated, but not of a concerning value. She lied down and rested. Family member came to pick her up to go home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2325378

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

gering
Staat
MI
Alter
59,0
Geschlecht
M
Eingang
17.06.2022
Impfdatum
10.03.2022
Beginn
10.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product preparation issue Underdose

Symptomtext

Covid19 Pfizer Gray Top was dilute with 1.8 ml of diluent in error. Patient received diluted dose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product preparation issue
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
None
Vorgeschichte
Type II, Diabetes, Hyperlipidemia, Back Pain, Neuropathy
Andere Medikamente
Lipitor, Jardiance, Neurontin, Motrin, Glucophage
Allergien
Iodinated Contrast Media
Vorherige Impfungen
-

VAERS 2036364

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

gering
Staat
OH
Alter
17,0
Geschlecht
F
Eingang
14.01.2022
Impfdatum
14.01.2022
Beginn
14.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

Patient requested a flu vaccine along with her Pfizer Booster. Patient verbalized that she was 18 when I asked. I administered a Flublok vaccination in her right deltoid along with her Pfizer Booster in her left deltoid. Patient waited the 15 minutes post administration without any concerns. After she left, upon documentation I realized that she was 17yo. I notified my healthcare provider and filled out appropriate reports.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1995900

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

gering
Staat
IL
Alter
15,0
Geschlecht
F
Eingang
31.12.2021
Impfdatum
11.12.2021
Beginn
11.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

patient is 15 years old and received a vaccine indicated for 18+ only. patient didnt experience any side effects

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
unknown - pt given flublok when under 18.
Allergien
n/a
Vorherige Impfungen
-

VAERS 1980895

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

gering
Staat
OH
Alter
17,0
Geschlecht
M
Eingang
25.12.2021
Impfdatum
17.12.2021
Beginn
17.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Off label use Product administered to patient of inappropriate age

Symptomtext

This case involves a 17 years old male patient who received a dose of flublok, with no reported adverse event while receiving vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient received unknown concomitant medication of Pfizer. On 17-Dec-2021, the patient received 0.5 ml dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE, once with lot UJ723AA via intramuscular route in the right deltoid as prophylactic immunization. On 17-DEC-2021 the patient developed a non-serious "17 yo paitent received a dose of flublok, with no reported adverse event" (off label use) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE. Action taken with QUADRIVALENT RECOMBINANT INFLUENZA VACCINE (FLUBLOK QIV) was not applicable. It was not reported if the patient received a corrective treatment for the event (17 yo paitent received a dose of FLUBLOK, with no reported adverse event). At time of reporting, the outcome was Unknown for the event 17 yo paitent received a dose of flublok, with no reported adverse event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1968085

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

gering
Staat
OH
Alter
17,0
Geschlecht
M
Eingang
21.12.2021
Impfdatum
21.12.2021
Beginn
21.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

FLUBLOK QUAD given to a 17 year old male patient; indicated for 18 years and older. patient left facility in stable condition.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 1959485

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723aa

gering
Staat
OH
Alter
17,0
Geschlecht
M
Eingang
17.12.2021
Impfdatum
17.12.2021
Beginn
17.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

Patient was 17 years old and Flublok is approved for >18.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1862176

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

gering
Staat
WA
Alter
12,0
Geschlecht
F
Eingang
11.11.2021
Impfdatum
11.11.2021
Beginn
11.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

patient was administered Flublok vaccine- it is indicated for 18+ years of age. patient was 13yrs old

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 1793555

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge uj723aa

gering
Staat
TN
Alter
15,0
Geschlecht
F
Eingang
16.10.2021
Impfdatum
25.09.2021
Beginn
25.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

She was only 15 and flublok is only approved in 18 and above

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
unknown
Allergien
none
Vorherige Impfungen
-

VAERS 1793476

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

gering
Staat
TN
Alter
15,0
Geschlecht
F
Eingang
16.10.2021
Impfdatum
25.09.2021
Beginn
25.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error Product administered to patient of inappropriate age

Symptomtext

FLUBLOK was mistakenly administered to an underage patient with no adverse event; Initial information was received on 08-Oct-2021 regarding an unsolicited valid non-serious case received from a pharmacist via consumer via physician via phone (Inquiry Number: 00804698). This case involves a 15-years old female patient who was mistakenly administered INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] with no adverse event (product administered to patient of inappropriate age). The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided. On 25-Sep-2021, the patient received a 0.5ml dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number: UJ723AA and expiry date: 30-Jun-2022 via intramuscular route in the right deltoid for prophylactic vaccination. It was of actual medication error due to inappropriate age at vaccine administration (latency: same day). It was reported "FLUBLOK was mistakenly administered to an underage patient, caller would like to know safety and how to proceed." At the time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1774838

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

gering
Staat
NY
Alter
62,0
Geschlecht
F
Eingang
09.10.2021
Impfdatum
29.09.2021
Beginn
29.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Eye swelling Hypersensitivity Swelling of eyelid Throat irritation

Symptomtext

feeling groggy; throat is itchy; allergic reaction; right eye began swelling/ both eyes are swollen shut; Initial information received on 30-Sep-2021 regarding an unsolicited valid non-serious case from a consumer/non-healthcare professional via regulatory authority (under reference 00792629). This case involves a 62 years old female patient who had allergic reaction (hypersensitivity) after receiving QUADRIVALENT RECOMBINANT INFLUENZA VACCINE (FLUBLOK QIV) and feeling groggy (somnolence), after receiving DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL). The patient's past vaccination(s) included Influenza vaccine (lot number and expiration date were not reported) via unknown route in an unknown administration site for prophylactic vaccination. It was also reported that the patient had several flu shots in the past, probably five flu shots in her lifetime. The patient's past medical history, medical treatment(s), concomitant medication(s) and family history were not provided. On 29-Sep-2021 at 10:00AM EST, the patient received a dose of suspect FLUBLOK QIV (Total, lot UJ723AA and expiration date: 30-Jun-2022) via unknown route in the left arm for prophylactic vaccination. On an unknown date, the patient received a dose of suspect BENADRYL (50 mg, lot number and expiration date were not reported) via unknown route for Hypersensitivity. On 29-Sep-2021, the patient developed a non-serious allergic reaction (hypersensitivity) and right eye began swelling (eye swelling) on the same day following the administration of vaccine. On 30-Sep-2021, the patient's both eyes are swollen shut (eye swelling, non-serious) and throat is itchy (throat irritation, non-serious), one day following the administration of vaccine. On an unknown date, the patient was feeling groggy (somnolence, non-serious) (unknown latency) following the administration of BENADRYL. It was reported "Caller (patient) reporting allergic reaction to a flu vaccine. Caller states that she does not know which vaccine was administered to her but has the lot number and expiration date and is sure it is a SANOFI product. The caller states the vaccine was administered on 29SEP2021 at 10:00AM EST and shortly after in the parking lot on the way out, the caller's right eye began swelling. Caller states she was able to drive home but on 30SEP201 at time of call both eyes are swollen shut and her throat is itchy. Caller states she has spoken to the clinic where the shot was administered. Patient states that she is calling to let the company know about her reaction and to ask for the name of the flu vaccine that she received. Patient states that she got the lot number and expiration date from her doctor's office. Called Sanofi Pasteur Customer Service and spoke with customer service. Informed the Sanofi Pasteur Customer Service representative of the lot number provided by the patient. Sanofi Pasteur Customer Service representative stated that the product name is FLUBLOK. Relayed the information to the patient that the product name associated with the lot number provided is FLUBLOK. I only saw a small vial with a red top. My daughter also works in the pharmaceutical industry and she said that you all would need to know about my reaction. I am feeling groggy now. That is probably because I have been taking Benadryl every four hours. I can't drive. I can't put my contacts in. After I get off the phone with you and am going to go back and take a nap." No laboratory data were reported. Action taken with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL) was unknown. The patient was given 50mg of antihistamine every four hours as a corrective treatment. At time of reporting, the outcome was unknown for the reported events.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Eye swelling
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
BENADRYL
Allergien
-
Vorherige Impfungen
-

VAERS 1774823

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

gering
Staat
AR
Alter
-
Geschlecht
F
Eingang
09.10.2021
Impfdatum
25.09.2021
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

A patient under the age of 18 received flublok with no reported adverse event; Initial information received on 27-Sep-2021 regarding an unsolicited valid non-serious case from a pharmacist via Media Information (under the reference 00787298). This case involves an 11 years old female patient who received INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] under the age of 18 (product administered to patient of inappropriate age). The patient's past medical history, medical treatment(s), vaccination(s), Concomitant medication(s) and family history were not provided. On 25-Sep-2021, the patient received a dose of suspect FLUBLOK QIV (0.5 ml, total, lot UJ723AA and expiration date: 30-jun-2022) via intramuscular route in the left arm for prophylactic vaccination. It was an actual medication error due to vaccine administered to patient of inappropriate age. At time of reporting, the outcome was unknown for the reported event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1762152

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

gering
Staat
MA
Alter
38,0
Geschlecht
F
Eingang
05.10.2021
Impfdatum
04.10.2021
Beginn
05.10.2021
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Angioedema

Symptomtext

Angioedema of right eyelid, approximately 9hrs post injection of vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Angioedema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Hashimotos
Vorgeschichte
Hashimoto?s thyroiditis / hypothyroidism
Andere Medikamente
Synthroid 125mg daily po
Allergien
Dairy Allergy-Egg Sensitivity- hives
Vorherige Impfungen
-

VAERS 1761808

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge Uj723AA

gering
Staat
MA
Alter
15,0
Geschlecht
F
Eingang
05.10.2021
Impfdatum
04.10.2021
Beginn
04.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Product administered to patient of inappropriate age

Symptomtext

Pt given adult flublok instead of fluzone. No adverse reactions at this time

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
EpiPen, Proair Inhaler, Junel FE1/20
Allergien
Apple, soy, and tree nuts
Vorherige Impfungen
-

VAERS 1732232

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

gering
Staat
IL
Alter
15,0
Geschlecht
F
Eingang
24.09.2021
Impfdatum
24.09.2021
Beginn
24.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

THIS PATIENT IS 15 YEARS OLD AND RECEIVED A THE FLUBLOK VACCINE FOR 18 YEARS AGE AND OVER. THE PATIENT HAS NOT REPORTED ANY ADVERSE EVENTS. FILLING OUT THIS FORM DUE TO THE FACT THE FLUBLOK WAS GIVEN FOR SOMEONE UNDER 18. WE DID NOTIFY HER PRIMARY CARE PHYSICIAN BUT HE HAS NOT RETURNED THE CALL

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 1709172

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ723AA

gering
Staat
ID
Alter
58,0
Geschlecht
F
Eingang
17.09.2021
Impfdatum
17.09.2021
Beginn
17.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

Patient came into the flu clinic and was asked by pharmacy personel if she was getting her flu vaccine. Patient handed the healthcare worker her paperwork. Patient was actually seeking a COVID-19 vaccine. Patient was given Flublok without verifying the vaccine she was about to receive. Patient later returned and asked if she received the flu vaccine or her covid vaccine, when pharmacist replied that she was given the flu shot, she stated she did not want the flu shot and wanted the COVID vaccine. Patient stated that she rarely got the flu vaccine and did not want it at this time. Patient then received the appropriate COVID-19 vaccine (Pfizer).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1693499

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge uj723aa

gering
Staat
NE
Alter
61,0
Geschlecht
F
Eingang
12.09.2021
Impfdatum
06.09.2021
Beginn
10.09.2021
Tage bis Beginn
4,0
Dosis
1
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cellulitis

Symptomtext

Pt called a few days post immunizations and reported sever cellulitis which need to be treated by a medical doctor

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cellulitis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-